NIVELPHARMA

NIVELPHARMA has been active since 2003 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €64,316 and a net result of €65,451. Equity is growing by ~40.6% per year across the filed fiscal years. Its solvency ranks better than 25% of 12386 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).